scispace - formally typeset
S

Siddhartha Dutta

Researcher at All India Institute of Medical Sciences

Publications -  64
Citations -  765

Siddhartha Dutta is an academic researcher from All India Institute of Medical Sciences. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 7, co-authored 41 publications receiving 166 citations.

Papers
More filters
Journal ArticleDOI

The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future.

Brian Godman, +81 more
TL;DR: In this paper, the authors assess current utilisation rates for insulins, especially long-acting insulin analogues, and the rationale for patterns seen, across multiple countries to inform strategies to enhance future utilisation of insulin analogue biosimilars to benefit all key stakeholders.
Journal ArticleDOI

Analysis of Neurological Adverse Events Reported in VigiBase From COVID-19 Vaccines

TL;DR: The vaccines should be monitored for These neurological AEs reported in VigiBase should not be taken as conclusive and mass vaccination should be carried out to control the pandemic until a definite link of these adverse effects is established.
Journal ArticleDOI

A systematic review and meta-analysis of efficacy and safety of Romosozumab in postmenopausal osteoporosis.

TL;DR: Romosozumab is a monoclonal antibody that acts against the sclerostin pathway leading to enhanced bone formation and reduced bone resorption in patients with osteoporosis as mentioned in this paper.
Journal ArticleDOI

Current utilization patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future.

TL;DR: In this article, the authors report that prevalence rates for diabetes mellitus continue to rise, which, coupled with increasing costs of complications, has appreciably increased expenditure in recent years.